0
Skip to Content
Brookstreet Equity Partners LLP
Home
Apply For Investment
Join Our Network
Team
Thesis
Partners
Testimonials
AI
News
ESG
Awards
Legacy
Contact
Disclaimer
Privacy Policy
Brookstreet Equity Partners LLP
Home
Apply For Investment
Join Our Network
Team
Thesis
Partners
Testimonials
AI
News
ESG
Awards
Legacy
Contact
Disclaimer
Privacy Policy
Home
Apply For Investment
Join Our Network
Team
Thesis
Partners
Testimonials
AI
News
ESG
Awards
Legacy
Contact
Disclaimer
Privacy Policy

Follow us on LinkedIn

#BrookstreetEquity

Quick Menu

Home

Apply for Investment

Join Investors Network

Team

Thesis

Partners

Testimonials

AI

News

ESG

Awards

Contact

Disclaimer

Privacy Policy

About Us

Brookstreet Equity Partners LLP UK is a Member of the UK Private Capital formerly the British Private Equity & Venture Capital Association (BVCA).

Registered and Regulated by the Financial Conduct Authority (FCA).

Latest News

Featured
Longevity: The Final Frontier (Private Forum)
April 22, 2026
Longevity: The Final Frontier (Private Forum)
April 22, 2026
April 22, 2026
Merging agentic AI, MCP, and human-led insight in Private Equity
April 14, 2026
Merging agentic AI, MCP, and human-led insight in Private Equity
April 14, 2026
April 14, 2026
Dr Oliver Zolman Collaborates with Brookstreet Equity Partners as Executive in Residence
April 14, 2026
Dr Oliver Zolman Collaborates with Brookstreet Equity Partners as Executive in Residence
April 14, 2026
April 14, 2026
Brookstreet 2.0 Intelligence Release
April 9, 2026
Brookstreet 2.0 Intelligence Release
April 9, 2026
April 9, 2026
Dual Close Execution: AUTONOMO Ai & Perceptual Robotics
March 31, 2026
Dual Close Execution: AUTONOMO Ai & Perceptual Robotics
March 31, 2026
March 31, 2026

Headquarters

42 Berkeley Square
Mayfair
London W1J 5AW | UK

+44 (0) 207 318 0800

info@brookstreetequity.com

Office Hours:
Mon-Fri: 9am-5pm

Investors Login

@2026 Brookstreet Equity Partners LLP. All Rights Reserved. Disclaimer. Privacy Policy.

Private equity and venture capital investments are not appropriate for non-professional investors.